Trial · NCT03371017
Adverse events256
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 256
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo + Chemotherapy | 138 | 294 | 210 |
| other | Anaemia | Blood and lymphatic system disorders | Atezolizumab + Chemotherapy | 133 | 293 | 199 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo + Chemotherapy | 42 | 294 | 130 |
| other | Leukopenia | Blood and lymphatic system disorders | Atezolizumab + Chemotherapy | 52 | 293 | 153 |
| other | Lymphopenia | Blood and lymphatic system disorders | Placebo + Chemotherapy | 17 | 294 | 34 |
| other | Lymphopenia | Blood and lymphatic system disorders | Atezolizumab + Chemotherapy | 26 | 293 | 40 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo + Chemotherapy | 119 | 294 | 322 |
| other | Neutropenia | Blood and lymphatic system disorders | Atezolizumab + Chemotherapy | 108 | 293 | 341 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo + Chemotherapy | 54 | 294 | 123 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Atezolizumab + Chemotherapy | 52 | 293 | 117 |
| other | Hyperthyroidism | Endocrine disorders | Placebo + Chemotherapy | 0 | 294 | 0 |
| other | Hyperthyroidism | Endocrine disorders | Atezolizumab + Chemotherapy | 15 | 293 | 17 |
| other | Hypothyroidism | Endocrine disorders | Placebo + Chemotherapy | 12 | 294 | 13 |
| other | Hypothyroidism | Endocrine disorders | Atezolizumab + Chemotherapy | 25 | 293 | 29 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo + Chemotherapy | 18 | 294 | 23 |
| other | Abdominal pain | Gastrointestinal disorders | Atezolizumab + Chemotherapy | 14 | 293 | 16 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo + Chemotherapy | 19 | 294 | 24 |
| other | Abdominal pain upper | Gastrointestinal disorders | Atezolizumab + Chemotherapy | 17 | 293 | 19 |
| other | Constipation | Gastrointestinal disorders | Placebo + Chemotherapy | 61 | 294 | 77 |
| other | Constipation | Gastrointestinal disorders | Atezolizumab + Chemotherapy | 61 | 293 | 87 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03371017/events